Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MATCH: FMT for Recurrent C. Difficile Prevention
NCT03005379Phase 3Terminated
- Sponsor
- VA Office of Research & Development
- Start
- Nov 2018
- Primary completion
- Aug 2022
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 3 trial of biologically active human fecal material in Clostridioides difficile infection (CDI), sponsored by VA Office of Research & Development. Started Nov 2018; status: terminated.
02
Drugs
biologically active human fecal material
03
Conditions
Clostridioides difficile infection (CDI)
Beyond the preview
Go deeper on NCT03005379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03005379.